$0.53 EPS Expected for Amedisys Inc (AMED)

October 14, 2017 - By Max Morgan

 $0.53 EPS Expected for Amedisys Inc (AMED)
Investors sentiment increased to 1.75 in 2017 Q2. Its up 0.69, from 1.06 in 2017Q1. It improved, as 9 investors sold Amedisys Inc shares while 42 reduced holdings. 32 funds opened positions while 57 raised stakes. 30.18 million shares or 2.20% less from 30.86 million shares in 2017Q1 were reported.
Loomis Sayles And L P stated it has 0% of its portfolio in Amedisys Inc (NASDAQ:AMED). Sivik Limited Liability Co holds 1.03% in Amedisys Inc (NASDAQ:AMED) or 44,607 shares. Acadian Asset Ltd Co accumulated 58,860 shares. 11,400 were reported by Louisiana State Employees Retirement. Geode Mngmt Ltd Company has invested 0.01% in Amedisys Inc (NASDAQ:AMED). 1,535 were reported by Us Bank De. Morgan Stanley holds 0% or 83,951 shares. Timpani Cap Lc reported 78,401 shares. Balyasny Asset Ltd Com reported 0.03% stake. Pillar Pacific Capital Mngmt Limited Liability Corporation holds 0.07% or 7,600 shares. Gilder Gagnon Howe And Llc holds 0.76% or 819,433 shares in its portfolio. Waddell & Reed Fincl Incorporated reported 0.01% of its portfolio in Amedisys Inc (NASDAQ:AMED). Northwestern Mutual Wealth Mgmt invested in 0% or 34 shares. First Trust Advsrs Ltd Partnership has invested 0% in Amedisys Inc (NASDAQ:AMED). 50,462 were reported by California State Teachers Retirement.

Since May 8, 2017, it had 1 insider purchase, and 4 selling transactions for $4.35 million activity. 35,496 shares valued at $2.09M were sold by Pernosky Lawrence R on Monday, May 8. Ginn Scott G had sold 23,828 shares worth $1.40M on Monday, May 8. The insider Hall Linda J. sold $300,800. Another trade for 500 shares valued at $29,845 was made by PERKINS BRUCE D on Thursday, May 25. The insider NETTERVILLE JAKE L sold 10,000 shares worth $600,000.

Analysts expect Amedisys Inc (NASDAQ:AMED) to report $0.53 EPS on November, 2.They anticipate $0.17 EPS change or 47.22 % from last quarter’s $0.36 EPS. AMED’s profit would be $17.96M giving it 22.55 P/E if the $0.53 EPS is correct. After having $0.62 EPS previously, Amedisys Inc’s analysts see -14.52 % EPS growth. The stock decreased 0.42% or $0.2 during the last trading session, reaching $47.8. About 323,474 shares traded or 0.92% up from the average. Amedisys Inc (NASDAQ:AMED) has risen 15.02% since October 14, 2016 and is uptrending. It has underperformed by 1.68% the S&P500.

Amedisys Inc (NASDAQ:AMED) Ratings Coverage

Among 14 analysts covering Amedisys Inc. (NASDAQ:AMED), 5 have Buy rating, 0 Sell and 9 Hold. Therefore 36% are positive. Amedisys Inc. had 27 analyst reports since September 1, 2015 according to SRatingsIntel. The stock of Amedisys Inc (NASDAQ:AMED) has “Buy” rating given on Monday, November 7 by Mizuho. The rating was maintained by Oppenheimer with “Outperform” on Thursday, March 10. The rating was maintained by RBC Capital Markets with “Hold” on Monday, September 18. The stock has “Neutral” rating by Mizuho on Wednesday, November 11. The stock of Amedisys Inc (NASDAQ:AMED) earned “Buy” rating by Mizuho on Tuesday, January 19. The rating was initiated by Benchmark on Friday, January 27 with “Hold”. The rating was maintained by RBC Capital Markets with “Hold” on Monday, July 10. On Monday, June 5 the stock rating was maintained by RBC Capital Markets with “Hold”. The stock of Amedisys Inc (NASDAQ:AMED) has “Neutral” rating given on Wednesday, January 13 by Robert W. Baird. As per Friday, May 6, the company rating was maintained by RBC Capital Markets.

Amedisys, Inc. is a healthcare services company. The company has market cap of $1.62 billion. The Company’s divisions are Home Health, Hospice, Personal Care and Other. It has a 40.67 P/E ratio. The Firm is a well-known provider of home health, hospice and personal care services.

More important recent Amedisys Inc (NASDAQ:AMED) news were published by: Globenewswire.com which released: “Scott Ginn Promoted to Chief Financial Officer at Amedisys” on October 06, 2017, also Globenewswire.com published article titled: “Seventy-One Amedisys Care Centers Receive SHPBest Awards”, Globenewswire.com published: “Amedisys Closes on Acquisition of Intercity Home Care” on October 02, 2017. More interesting news about Amedisys Inc (NASDAQ:AMED) was released by: Globenewswire.com and their article: “Amedisys Unveils Program for Its 60000 COPD Patients” with publication date: October 12, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com